Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs
about
Advancements in stem cells treatment of skeletal muscle wastingPerspectives of stem cell therapy in Duchenne muscular dystrophyDifferential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell TransplantationThe mdx mouse model as a surrogate for Duchenne muscular dystrophyGait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis.The golden retriever model of Duchenne muscular dystrophy.Evaluation of bone marrow mononuclear cells as an adjunct therapy to minced muscle graft for the treatment of volumetric muscle loss injuries.Injectable scaffold materials differ in their cell instructive effects on primary human myoblastsStem cell transplantation for muscular dystrophy: the challenge of immune response.Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsEffects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy.Coaxing stem cells for skeletal muscle repairManipulation of a quasi-natural cell block for high-efficiency transplantation of adherent somatic cells.Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients.Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophyNeuromuscular disorders: genes, genetic counseling and therapeutic trialsCanine models of Duchenne muscular dystrophy and their use in therapeutic strategies.Domestic animal models for biomedical research.Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies.Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone MarrowLong-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy.Hydrogel biomaterials and their therapeutic potential for muscle injuries and muscular dystrophies.Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.First study of intra-arterial delivery of myogenic mononuclear cells to skeletal muscles in primates.Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.Translational Research in Stem Cell Treatment of Neuromuscular Diseases
P2860
Q26822437-62557F43-93D8-49D1-B3C7-0958FA7E7CABQ27013613-2C03389D-3EBB-456A-A570-A644DCE252CAQ27309883-EB92AC98-6B42-460F-B587-C2B97A3FB58BQ28656377-DDD91082-5186-4EFD-858C-904B50CC4779Q33555880-59718D55-364A-4ECD-95A1-818FFF11919CQ33709114-9F0616DC-A6BD-4929-B795-F79173E31123Q33784964-80F6D423-5138-4B2C-81DA-553693E52477Q33887599-13315D6D-0709-4806-9E4F-E6BEB6E4F776Q33902416-B1F5BB6F-8617-4AC6-ABF7-1EF971C8B237Q34152280-0732717D-BA87-4CB5-837F-9199EE1D22C0Q34489678-5CC1A899-A3AE-4C11-AB25-F4BE882ABC46Q34964840-5D2EE5E8-E78A-4384-99DD-81952F1D68CAQ35653445-3C449788-28D9-4AF0-A02F-8C7D7A8A170FQ35664379-1C1770C5-A3D4-43E8-876D-9158D888C839Q36015171-480D60BD-7466-4C52-AB43-427117E77C4BQ36740284-712758AB-7EDA-4E40-A902-47CFDB39050EQ37217303-86CC8F7F-5738-4300-8ED0-DF96CE4ED46DQ37548291-C639F160-7530-496E-9B6A-7CDB64DBC0E4Q38029020-F8D371CE-A2A7-43E8-8435-08E29394954BQ38079633-DC608563-7941-4FF7-8FFA-9F8B311C2621Q38269131-25BF0711-F10E-4277-BBE7-959A72A1F354Q38391853-13BD5EE5-1814-4528-8F98-8B94FE008050Q38577279-3F703CB7-D153-417E-A5AD-265FC0CF9D77Q38954041-90F6201B-AE99-456F-9430-37E968B577E2Q40109350-60E5E016-F18A-4C13-9F97-152E6A94BF49Q48223753-16872F89-E9FA-4A14-9B5D-4A53E19F2BA4Q52714547-DFE85510-2DF2-4A8F-A4B4-742DAD1A1B71Q53083043-B564CD9B-DA94-4F7E-8D05-F2CE6DA7B2CCQ53097033-05C1E4CC-0BE6-40F4-8117-1F599C03C0ADQ59001351-20FBA8D8-E139-49CC-807B-25FE26A92B8F
P2860
Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@ast
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@en
type
label
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@ast
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@en
prefLabel
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@ast
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@en
P2093
P2860
P1476
Systemic delivery of allogenic ...... chenne muscular dystrophy dogs
@en
P2093
Benoît Fornasari
Blandine Lieubeau
Bruno Delorme
Caroline Le Guiner
Céline Zuber
Elisabeth Le Rumeur
Gregory Jouvion
Isabelle Leroux
Isabelle Testault
Jack-Yves Deschamps
P2860
P304
P356
10.1016/J.AJPATH.2011.07.022
P407
P577
2011-09-13T00:00:00Z